• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® TAG® THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® TAG® THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGU404015
Device Problem Insufficient Information (3190)
Patient Problems Bradycardia (1751); Death (1802); Rupture (2208); Aortic Dissection (2491); Blood Loss (2597); Vascular Dissection (3160)
Event Date 09/01/2017
Event Type  Death  
Manufacturer Narrative
(b)(4).Udi info: (b)(4).Results: the review of the manufacturing records for the device verified that this lot met all pre-release specifications.Results: an imaging evaluation is currently in progress.Conclusion: according to the conformable gore tag® thoracic endoprosthesis instructions for use, adverse events that may occur include, but are not limited to bleeding and death.
 
Event Description
On (b)(6) 2017 a patient underwent treatment for penetrating atherosclerotic ulcer of the thoracic aorta with a gore® tag® thoracic endoprosthesis.The device was placed at the level of the left common carotid artery, proximally.A left subclavian bypass was also performed.The procedure went well and the final angiographic run was reportedly satisfactory.On (b)(6) 2017, the patient was bradycardic.A ct showed a retrograde type a dissection.The patient was taken to surgery where it was found the dissection had ruptured and bled into the pericardium.The patient expired during the procedure.
 
Manufacturer Narrative
Updated.Results: the imaging evaluation stated the following: one time point available for evaluation; pre-implantation cta dated (b)(6) 2017.The patient presents with a bovine arch.The length from the lsa to the lesion appears to be ~2.3cm, by outer curve length.The length of the lesion appears to be approximately 4.6cm, by outer curve length.Images provided do not allow for evaluation in relationship to this event.
 
Event Description
On (b)(6) 2017 a patient underwent treatment for penetrating atherosclerotic ulcer of the thoracic aorta with a conformable gore® tag® thoracic endoprosthesis.The device was placed at the level of the left common carotid artery, proximally.A left subclavian bypass was also performed.The procedure went well and the final angiographic run was reportedly satisfactory.On (b)(6) 2017, the patient was bradycardic.A ct showed a retrograde type a dissection.The patient was taken to surgery where it was found the dissection had ruptured and bled into the pericardium.The patient expired during the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® TAG® THORACIC ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WOODY MOUNTAIN B/P
3750 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
heidi inskeep
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6881194
MDR Text Key86836236
Report Number2017233-2017-00488
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/26/2019
Device Catalogue NumberTGU404015
Device Lot Number15419424
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/20/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received10/19/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/26/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age84 YR
-
-